Medicine

Proponents of the trials say they can be run safely and help to identify effective vaccines, but others have questioned their value

A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021

A medical student describes winning her fight to change an equation that prevented Black people from getting crucial treatment

It’s not just “antiscience thinking”

Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce

A stretch of Neandertal DNA has been associated with some cases of severe COVID-19, but it’s unclear how much of a risk it poses. Christopher Intagliata reports. 

China has promised vaccines to many countries, but whether it can meet its commitments is unclear

New Nobel laureate in chemistry Jennifer Doudna talks about various applications of the gene-editing tool CRISPR.

Charles Rice, who today shared the Nobel Prize in Physiology or Medicine for the discovery of the hepatitis C virus, talked about how rapidly research now occurs, compared with his early work.

Harvey J. Alter, Michael Houghton and Charles M. Rice share the award for identifying the virus behind the blood-borne liver disease

Proponents say yes, but scientific studies on the effectiveness of this chemical derived from cannabis are a mixed bag

Book recommendations from the editors of Scientific American